[SARS-Cov-2 vaccine's acceptance among pregnant women-A cross-sectional survey].

ABSTRACT:

Objective

SARS-CoV-2 is more likely to cause severe cases in pregnant women. They were part of the priority groups since April 2021 to benefit from SARS-CoV-2 vaccination before its extent to general population. This contribution aims to evaluate, in the postpartum period, the achievement of COVID-19 vaccination and factors associated in women during their pregnancy.

Material and method

Multicenter cross-sectional survey study conducted from September to December 2021 with online self-questionnaire. All postpartum patients hospitalized in one of the 6 participating maternity hospitals were invited to answer. The questionnaire asked patients about their demographic characteristics, vaccination modalities, vaccine tolerance, and their general perception of vaccination.

Resu

SUBMITTER: Hure M 

PROVIDER: S-EPMC9335352 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature